Newsfiscal.ai
Genprex Identifies TROP2 as Potential Predictive Biomarker for REQORSA
· Published
Article summary
Genprex announced new research identifying TROP2 expression as a potential predictive biomarker for response to its REQORSA gene therapy in non-small cell lung cancer.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…